Cure Accelerationism

Every year, millions die waiting for treatments that could exist but don’t—because our current system makes medical innovation unnecessarily slow, expensive, and restricted. Clinical trials today cost an average of $56 million, take 12-15 years, and exclude 80% of patients who might benefit. This broken system leaves 95% of rare diseases without treatments while healthcare costs spiral out of control.

The Solution: Four Pillars

A. Global Decentralized Clinical Trial Platform

  • Cuts trial costs by 95% (from $56M to $2.4M)
  • Reduces timeline from 12-15 years to 2-3 years
  • Enables participation from anywhere in the world
  • Automates data collection and safety monitoring
  • Eliminates geographical and socioeconomic barriers to participation

B. Treatment Outcomes Database

  • First global, open-source database of treatment outcomes
  • Real-time tracking of both benefits and side effects
  • Enables rapid identification of what works (and what doesn’t)
  • Powers AI-driven insights for better treatment decisions
  • Creates unprecedented transparency in healthcare

C. Right to Trial Initiative

  • Gives patients legal right to access experimental treatments
  • Ends arbitrary exclusion from clinical trials
  • Enables participation while maintaining rigorous safety monitoring
  • Democratizes access to cutting-edge treatments
  • Accelerates discovery through broader participation

D. Disease Prevention Savings Sharing Program

  • Revolutionary incentive model that rewards prevention and cures
  • Creates massive financial incentives for true cures (example: a diabetes cure could earn a manufacturer $147 billion while saving healthcare systems an equal amount)
  • Manufacturers receive 50% of verified healthcare savings from prevention
  • Healthcare systems automatically capture 50% of all cost reductions
  • Shifts focus from symptom management to prevention
  • Example savings at scale:
  • Type 2 Diabetes cure: $294B total annual savings ($147B each to healthcare systems and manufacturer)
  • Heart Disease prevention: $200B+ potential annual savings
  • Obesity prevention: $180B+ potential annual savings

3. Impact

For Patients:

  • Access to treatments years or decades sooner
  • Right to try promising treatments regardless of location or status
  • Better treatments through more comprehensive data
  • Lower healthcare costs through prevention
  • Hope for currently untreatable conditions

For Healthcare Systems:

  • Dramatic reduction in chronic disease burden
  • Guaranteed 50% of all cost savings from new preventive treatments
  • Better treatment decisions through real-world data
  • Reduced administrative overhead
  • More efficient resource allocation

For Innovation:

  • 95% reduction in development costs
  • 80% reduction in development time
  • Removal of artificial barriers to research
  • Multi-billion dollar incentives for developing true cures
  • Direct financial rewards tied to real patient outcomes

For Society:

  • Millions of lives saved through faster treatment development
  • Potential for trillions in healthcare savings over time
  • More equitable access to healthcare
  • Acceleration of medical knowledge
  • Transformation from a sick-care to a healthcare system

4. The Vision

We avoid a system that profits from ongoing illness and excludes most patients from promising treatments. We can create one that rewards:

  1. prevention
  2. cures
  3. accessibility and affordability

Consider this: Currently, a company can earn billions by keeping patients dependent on daily medications. Under this new system, they could earn even more by actually curing the diseases. Meanwhile, healthcare systems save billions. It’s a win-win-win that fundamentally realigns incentives toward better health outcomes.

The technology exists. The need is clear. The potential impact is unprecedented. All that’s missing is the will to change.


Leave a Reply